 |
nicotinamide riboside |
|---|---|
| Trade Name | Niasun |
| Orphan Indication | Mitochondrial encephalomyopathy lactic acidosis and stroke-like episodes |
| USA Market Approval | USA |
| USA Designation Date | 2017-01-25 00:00:00 |
| Sponsor | Rejuvenation Therapeutics;774 Mays Boulevard, 10-509 PMB;Incline Village, Nevada, 89451 |
